News
Photoactivable drugs are activated when irradiated by a beam of light—via an optical fiber—thus generating a controlled and ...
Scientists discovered a hidden CB₁ receptor pocket and engineered a drug to exploit it, offering promise of safer, more ...
6d
Vietnam Investment Review on MSNTRD205, a First-in-Class Pain Drug, Moves to Phase II with First Patient DosedGlobal AT2R-targeted drug development remains nascent, with only a few competitors like Lilly-partnered CFTX-1554 (Phase I).
Photoactivable drugs are activated when irradiated by a beam of light — via an optical fibre — thus generating a controlled ...
A new wireless, battery-free photopharmacology protocol, based on the local and controlled release of light-activable drugs, proves its efficacy in ...
The phase 2a trial showed rapid onset as well as long-lasting pain reduction with Algiax's allosteric GABAA-receptor modulator ... there were no central nervous system side effects – such ...
Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...
Mount Sinai researchers have discovered distinct roles for two dopamine receptors located on nerve cells within the portion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results